DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,440,335 | +102035.0% | 38,051 | -1.2% | 3.45% | +7.5% |
| Q2 2023 | $9,243 | -1.9% | 38,514 | +3.0% | 3.21% | -9.0% |
| Q1 2023 | $9,426 | -4.5% | 37,400 | +0.5% | 3.53% | -5.7% |
| Q4 2022 | $9,873 | -100.0% | 37,197 | -67.7% | 3.74% | -5.0% |
| Q3 2022 | $29,753,000 | +206.7% | 115,191 | +201.0% | 3.94% | +7.6% |
| Q2 2022 | $9,702,000 | -11.7% | 38,273 | +2.2% | 3.66% | +1.0% |
| Q1 2022 | $10,987,000 | -9.5% | 37,457 | +1.5% | 3.63% | -9.0% |
| Q4 2021 | $12,139,000 | +3.4% | 36,895 | -4.3% | 3.99% | -6.9% |
| Q3 2021 | $11,743,000 | +14.1% | 38,570 | +0.5% | 4.28% | +16.5% |
| Q2 2021 | $10,295,000 | +15.7% | 38,363 | -3.0% | 3.68% | +4.2% |
| Q1 2021 | $8,900,000 | +2.5% | 39,541 | +1.1% | 3.53% | -1.3% |
| Q4 2020 | $8,684,000 | +0.4% | 39,092 | -2.7% | 3.57% | -13.1% |
| Q3 2020 | $8,648,000 | +21.5% | 40,160 | -0.2% | 4.11% | +9.2% |
| Q2 2020 | $7,115,000 | +28.2% | 40,238 | +0.3% | 3.77% | +1.9% |
| Q1 2020 | $5,550,000 | -10.5% | 40,102 | -0.8% | 3.69% | +17.3% |
| Q4 2019 | $6,203,000 | +4.0% | 40,421 | -2.1% | 3.15% | -1.6% |
| Q3 2019 | $5,964,000 | +0.8% | 41,289 | -0.3% | 3.20% | +3.2% |
| Q2 2019 | $5,918,000 | +4.3% | 41,404 | -3.6% | 3.10% | +8.3% |
| Q1 2019 | $5,673,000 | +37.3% | 42,966 | +7.2% | 2.86% | +16.3% |
| Q4 2018 | $4,132,000 | – | 40,065 | – | 2.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |